Skip to main content
Top
Published in: Cancer Causes & Control 10/2008

01-12-2008 | Original Paper

Abstracting height and weight from medical records, and breast cancer pathologic factors

Authors: Archana J. McEligot, Theresa Im, Robert O. Dillman, John G. West, Rana Salem, Reina Haque, Hoda Anton-Culver

Published in: Cancer Causes & Control | Issue 10/2008

Login to get access

Abstract

Cancer registries routinely collect data on clinicopathologic factors, but rarely abstract anthropometric variables. We conducted a chart review study, examining the feasibility of abstracting weight, height, alcohol use, and smoking from medical records in women (n = 1,974) diagnosed with invasive breast cancer, and investigated the association between the abstracted variables with clinicopathologic features. Qualitative data were reviewed and categorized. Frequencies of the abstracted data, and demographic and clinicopathologic variables were calculated. Logistic regression models measured the relationship between the outcome variables, tumor size, stage of disease, and estrogen/progesterone (ER/PR) status with the abstracted variables. Data on current alcohol-use/no-use, current-smoker/non-smoker, and height/weight data were obtained on 96%, 97%, and 88–89% of the participants, respectively. The multivariate analysis showed that overweight (≥25 kg/m2) women had significantly larger (≥2 cm) tumor size compared with normal weight for both women <50 years (OR = 1.79; 95% CI = 1.14–2.81; p ≤ 0.05) and for women ≥50 years at diagnosis (OR = 1.58; 95% CI = 1.19–2.09; p ≤ 0.05). These results suggest that abstracting current height and weight via medical records is feasible, and at minimum, current alcohol use and smoking status can be ascertained. In addition, being overweight was significantly associated with cancer clinicopathologic/prognostic factors, which has implications for monitoring etiologic factors that could be associated with cancer trends, incidence, and survival. Therefore routine collection of height and weight via cancer registries should be explored further.
Literature
1.
go back to reference Baumgartner KB, Hunt WC, Baumgartner RN et al (2004) Association of body composition and weight history with breast cancer prognostic markers: divergent pattern for Hispanic and non-Hispanic White women. Am J Epidemiol 160:1087–1097. doi:10.1093/aje/kwh313 PubMedCrossRef Baumgartner KB, Hunt WC, Baumgartner RN et al (2004) Association of body composition and weight history with breast cancer prognostic markers: divergent pattern for Hispanic and non-Hispanic White women. Am J Epidemiol 160:1087–1097. doi:10.​1093/​aje/​kwh313 PubMedCrossRef
3.
go back to reference Maehle BO, Tretli S, Skjaerven R, Thorsen T (2001) Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status. Breast Cancer Res Treat 68:159–169. doi:10.1023/A:1011977118921 PubMedCrossRef Maehle BO, Tretli S, Skjaerven R, Thorsen T (2001) Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status. Breast Cancer Res Treat 68:159–169. doi:10.​1023/​A:​1011977118921 PubMedCrossRef
5.
go back to reference Hunter DJ, Willet WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15:110–132PubMed Hunter DJ, Willet WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15:110–132PubMed
6.
go back to reference Negri E, La Vecchia C, Bruzzi P et al (1988) Risk factors for breast cancer: pooled results from three Italian case–control studies. Am J Epidemiol 128:1207–1215PubMed Negri E, La Vecchia C, Bruzzi P et al (1988) Risk factors for breast cancer: pooled results from three Italian case–control studies. Am J Epidemiol 128:1207–1215PubMed
11.
go back to reference Daniell HW (1988) Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 62:429–435. doi:10.1002/1097-0142(19880715)62:2<429::AID-CNCR2820620230>3.0.CO;2-4PubMedCrossRef Daniell HW (1988) Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer 62:429–435. doi:10.1002/1097-0142(19880715)62:2<429::AID-CNCR2820620230>3.0.CO;2-4PubMedCrossRef
12.
go back to reference Manjer J, Malina J, Berglund G et al (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91:580–584. doi:10.1002/1097-0215(200002)9999:9999<::AID-IJC1091>3.0.CO;2-VPubMedCrossRef Manjer J, Malina J, Berglund G et al (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91:580–584. doi:10.1002/1097-0215(200002)9999:9999<::AID-IJC1091>3.0.CO;2-VPubMedCrossRef
15.
go back to reference Chu SY, Stroup NE, Wingo PA, Lee NC, Peterson HB, Gwinn ML (1990) Cigarette smoking and the risk of breast cancer. Am J Epidemiol 131:244–253PubMed Chu SY, Stroup NE, Wingo PA, Lee NC, Peterson HB, Gwinn ML (1990) Cigarette smoking and the risk of breast cancer. Am J Epidemiol 131:244–253PubMed
16.
go back to reference Couch FJ, Cerhan JR, Vierkant RA et al (2001) Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 10:327–332PubMed Couch FJ, Cerhan JR, Vierkant RA et al (2001) Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 10:327–332PubMed
17.
go back to reference Reynolds P, Hurley S, Goldberg DE et al (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96:29–37PubMed Reynolds P, Hurley S, Goldberg DE et al (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 96:29–37PubMed
18.
go back to reference Terry PD, Rohan TE (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11:953–971PubMed Terry PD, Rohan TE (2002) Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev 11:953–971PubMed
19.
go back to reference Suzuki R, Ye W, Rylander-Rudqvist T, Saji S, Colditz GA, Wolk A (2005) Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst 97:1601–1608PubMedCrossRef Suzuki R, Ye W, Rylander-Rudqvist T, Saji S, Colditz GA, Wolk A (2005) Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst 97:1601–1608PubMedCrossRef
20.
go back to reference Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case–control study. Br J Cancer 59:119–125PubMed Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case–control study. Br J Cancer 59:119–125PubMed
21.
go back to reference Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12:1053–1060PubMed Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12:1053–1060PubMed
22.
go back to reference Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMed Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMed
23.
go back to reference Yoo KY, Tajima K, Miura S et al (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case–control analysis. Am J Epidemiol 146:307–314PubMed Yoo KY, Tajima K, Miura S et al (1997) Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case–control analysis. Am J Epidemiol 146:307–314PubMed
25.
go back to reference MMWR (2002) Recent trends in mortality rates for four major cancers, by sex and race/ethnicity—United States, 1990–1998. From the Centers for Disease Control and Prevention 287:1391–1392 MMWR (2002) Recent trends in mortality rates for four major cancers, by sex and race/ethnicity—United States, 1990–1998. From the Centers for Disease Control and Prevention 287:1391–1392
26.
go back to reference Ries LAG, Eisner MP, Kosary CL et al (2000) SEER cancer statistics review, 1973–1997. National Cancer Institute, Bethesda, MD Ries LAG, Eisner MP, Kosary CL et al (2000) SEER cancer statistics review, 1973–1997. National Cancer Institute, Bethesda, MD
27.
go back to reference Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183PubMedCrossRef Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183PubMedCrossRef
28.
go back to reference Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMed Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMed
29.
go back to reference Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB (1988) Incidence of lung cancer by histological type from a population-based registry. Cancer Res 48:6580–6583PubMed Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB (1988) Incidence of lung cancer by histological type from a population-based registry. Cancer Res 48:6580–6583PubMed
30.
go back to reference Seiffert JE, Price WT, Gordon B (1990) The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage 11:59–73PubMed Seiffert JE, Price WT, Gordon B (1990) The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage 11:59–73PubMed
32.
go back to reference Ziogas A, Gildea M, Cohen P et al (2000) Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9:103–111PubMed Ziogas A, Gildea M, Cohen P et al (2000) Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9:103–111PubMed
33.
go back to reference Verreault R, Brisson J, Deschenes L, Naud F (1989) Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. Am J Epidemiol 129:260–268PubMed Verreault R, Brisson J, Deschenes L, Naud F (1989) Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors. Am J Epidemiol 129:260–268PubMed
35.
go back to reference Watzlaf VJ, Katoh A, D’Amico F (1996) Obstacles encountered in the use of the medical record and cancer registry abstract in breast cancer research. Top Health Inf Manage 17:25–33PubMed Watzlaf VJ, Katoh A, D’Amico F (1996) Obstacles encountered in the use of the medical record and cancer registry abstract in breast cancer research. Top Health Inf Manage 17:25–33PubMed
37.
go back to reference La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, Decarli A (1997) Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer 75:441–444PubMed La Vecchia C, Negri E, Franceschi S, Talamini R, Bruzzi P, Palli D, Decarli A (1997) Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer 75:441–444PubMed
38.
39.
go back to reference Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92:720–729. doi:10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-TPubMedCrossRef Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92:720–729. doi:10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-TPubMedCrossRef
40.
go back to reference Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD (1995) Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer 76:275–283. doi:10.1002/1097-0142(19950715)76:2<275::AID-CNCR2820760218>3.0.CO;2-6PubMedCrossRef Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD (1995) Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer 76:275–283. doi:10.1002/1097-0142(19950715)76:2<275::AID-CNCR2820760218>3.0.CO;2-6PubMedCrossRef
42.
go back to reference Brooks PJ (1997) DNA damage, DNA repair, and alcohol toxicity—a review. Alcohol Clin Exp Res 21:1073–1082PubMed Brooks PJ (1997) DNA damage, DNA repair, and alcohol toxicity—a review. Alcohol Clin Exp Res 21:1073–1082PubMed
43.
go back to reference Fan S, Meng Q, Gao B et al (2000) Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 60:5635–5639PubMed Fan S, Meng Q, Gao B et al (2000) Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 60:5635–5639PubMed
47.
go back to reference McCarthy EP, Burns RB, Freund KM et al (2000) Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 48:1226–1233PubMed McCarthy EP, Burns RB, Freund KM et al (2000) Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 48:1226–1233PubMed
Metadata
Title
Abstracting height and weight from medical records, and breast cancer pathologic factors
Authors
Archana J. McEligot
Theresa Im
Robert O. Dillman
John G. West
Rana Salem
Reina Haque
Hoda Anton-Culver
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 10/2008
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9192-z

Other articles of this Issue 10/2008

Cancer Causes & Control 10/2008 Go to the issue

Letter to the Editor

Prostate cancer screening

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine